Middle East Medical Devices Market (2025-2032)
The Middle East Medical Devices Market was valued at $6 billion in 2024. This market is expected to reach $8.8 billion by 2032 from an estimated $6.4 billion in 2025, at a CAGR of 4.6% during the forecast period of 2025-2032. Middle East Medical Devices Market Size & Forecast The growth of this market
- Published
- Nov 2024
- Pages
- 280
- Format
- PDF + Excel
- Report ID
- MR-1418
- Base year
- 2024
- 2024 · BASELINE
- $6.00B
- 2032
- $8.80B
- CAGR 2025–2032
- 4.6%
2024 baseline · 2025–2032 forecast at 4.6% CAGR · hover a bar for the value
Key highlights
By Product: The Monitoring Devices Segment to Dominate the Middle East Medical Devices Market in 2025
By Risk Type: The Moderate-risk Medical Devices Segment to Dominate the Middle East Medical Devices Market in 2025
By Application: In 2025, the Cardiology Segment is Expected to Dominate the Middle East Medical Devices Market
By End User: In 2025, the Hospitals & Clinics Segment is Expected to Account for the Largest Share of the Middle East Medical Devices Market
By Geography: Saudi Arabia Dominates the Middle East Medical Devices Market in 2025
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 280 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2024 |
| CAGR (Value) | 4.6% |
| Market Size (Value) | USD 8.8 Billion by 2032 |
| Segments Covered | By Product · Monitoring Devices · Diagnostic devices · Drug delivery devices · Surgical Devices · Bio implants & Stimulation Devices · Automation & Robotics · Imaging Devices · Other Devices · (Note: Other devices include immunoassay, gynecology, pediatric, urology, and cryogenic.) · By Risk Type · Low-risk Medical Devices · Moderate Risk Medical Devices · High-risk Medical Devices · By Application · Cardiology · Oncology · Gynecology · Orthopedics · Diabetes · General Surgery · Dental Application · Ear, Nose, and Throat · Ophthalmology · Other Applications · By End User · Hospitals & Clinics · Ambulatory Surgery Centers · Diagnostic Centers & Laboratories · Pharmacies · Other End Users · (Note: Other end users include dental care clinics, blood banks, academic institutes, and ambulatory surgical centers.) |
| Countries Covered | Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Bahrain, Egypt, Israel, Oman, Turkey, Jordan, Lebanon and the Rest of the Middle East |
| Key Companies | Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S), Abbott Laboratories (U.S.), Smith+Nephew. (U.K.), Coloplast Corp. (Denmark), Saudi Mais CO. (Saudi Arabia), Zimmer Biomet (U.S), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company. (U.S), Olympus Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), and Cardinal Health. (U.S.) |
Report overview
Segments covered: product, monitoring device, diagnostic device, drug delivery device, surgical device, bio implants & stimulation device, automation & robotic, imaging device, other device, risk type, low-risk medical device, moderate risk medical device, high-risk medical device, application, cardiology, oncology, gynecology, orthopedic, diabete, general surgery, dental application, ear, nose, throat, ophthalmology, other application, end user, hospitals & clinic, ambulatory surgery center, diagnostic centers & laboratory, pharmacy, other end user.
The growth of this market is driven by the increasing prevalence of chronic diseases coupled with geriatric populations, supportive initiatives for strengthening healthcare in Saudi Arabia and UAE, and the expansion of medical device companies in the Middle East & Middle East. Furthermore, expanding healthcare services in the Middle East and emerging medical tourism in Middle Eastern countries are expected to generate growth opportunities for the stakeholders in this market.
Report infographic
Market dynamics
4 factors across 2 forcesIncreasing Prevalence of Chronic Diseases Coupled with Geriatric Population
The growing global burden of the geriatric population is contributing to an increase in chronic diseases such as cancer, diabetes, kidney disorders, stroke, and heart disease. According to the National Institute of Health (NIH), chronic diseases were a major public health issue in 2021, with Oman reporting 185.75 deaths per 100,000 population due to these conditions. The rising prevalence of chronic diseases is attributed to factors such as tobacco use, physical inactivity, alcohol consumption, unhealthy diets, air pollution, genetics, and viruses. Cancer, in particular, has become one of the most costly diseases worldwide, significantly impacting individuals' lives globally. For example, according to GLOBOCAN, 28,113 new cancer cases were diagnosed in Saudi Arabia in 2022, and this number is expected to rise to 39,900 by 2032.
The geriatric population is more vulnerable to a range of chronic diseases, including hearing loss, chronic obstructive pulmonary disease (COPD), diabetes, dementia, joint pain, osteoarthritis, and refractive errors. According to the Telecommunications and Digital Government Regulatory Authority (TDRA), in 2021, 11.8% of the UAE's population was affected by diabetes. Medical devices play a crucial role in treating chronic conditions and supporting surgeries. As the prevalence of chronic diseases rises alongside the growing geriatric population, the demand for medical devices in the Middle East is expected to increase, driving market growth.
Technological Advancements in Medical Devices
In recent years, new medical devices with advanced features and greater efficiency have been introduced to the market, surpassing conventional devices. Ongoing research and development in medical devices have resulted in improved communication, enhanced patient care and safety, better access to medical records, more accurate diagnostics and treatment, and streamlined medical administration—all while reducing hospital costs. For example, in February 2025, Zylox-Tonbridge Medical Technology Co., Ltd. (China) received marketing approval from the Ministry of Health and Prevention in the United Arab Emirates for five medical devices, including the ZENFluxion Drug-coated PTA Balloon Catheter, ZENFlow HP PTA Balloon Catheter, ZENFlow PTA Balloon Catheter, ZENFlex Peripheral Stent System, and ZENFLEX Pro Peripheral Drug-eluting Stent System.
In addition, in December 2022, the government of Saudi Arabia collaborated with Medtronic plc (U.S.) to launch a ventilator for the intensive care unit (ICU). Therefore, technological advancements in medical devices are driving the medical device market.
Table of contents
12 chapters · 117 sections · 280 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Monitoring Devices | — |
By Product
- The monitoring devices segment is estimated to account for the largest share of the Middle East medical devices market.
- The large market share of this segment is attributed to the increasing demand for medical devices for surgical procedures in the Middle East, technological advancements in medical devices, and increasing healthcare expenditure.
- For instance, the United Arab Emirates Ministry of Finance (UAEMF) announced a budget for 2024-2026 of 4.8 billion (7.6% of the total general budget) for healthcare and community protection.
Competitive landscape
- October 2025
Olympus Corporation (Japan), a global medical technology company, received CE approval for three cloud-based AI endoscopy medical devices: CADDIE, CADU, and SMARTIBD. Olympus Corporation announced to commercialize these solutions in Europe and the Middle East.
- March 2024
Groupe ProductLife S.A.S. (France), a leading life science and consulting firm, acquired Healthcare Solutions (Morocco) to expand its global presence across the Middle East & Middle East region.
- January 2025
QIAGEN GmbH (Netherlands), the leading provider of sample and assay technologies, announced the expansion of its business in Middle Eastern countries such as Riyadh and Saudi Arabia with new regional headquarters and major projects.
- January 2025
Oman (Middle East) is supporting a nationwide tuberculosis screening program with the help of QIAGEN GmbH (Netherlands) Commercial Partner Taiba Medserv LLC, which provides thousands of QuantiFERON-TB Gold Plus assays to Oman’s people, which aims to test for latent tuberculosis (TB).
- January 2025
Meddist Company Limited (UAE) acquired the majority stake in Genpharm Services (UAE), a leading firm for rare diseases and specialty drugs in the MENAT region. The acquisition signifies a milestone for both healthcare and healthcare policies and for accelerating access to modern medical care.
- June 2022
Marubeni Corporation (Japan), a global leader in trading and investment in the healthcare sector, acquired Lunatus (Dubai), the largest pharmaceutical firm in the MENA region. This acquisition will help bring Japanese high-quality pharmaceuticals and medical devices to Middle East countries to meet the growing demand in the region.
- Medtronic plc · Ireland
- Koninklijke Philips N.V. · Netherlands
- GE HealthCare Technologies Inc. (U.S)
- Abbott Laboratories (U.S.)
- Smith+Nephew. (U.K.)
- Coloplast Corp. · Denmark
- Saudi Mais CO. · Saudi Arabia
- Zimmer Biomet (U.S)
- Siemens Healthineers AG · Germany
- F. Hoffmann-La Roche Ltd. · Switzerland
- Becton
- Dickinson and Company. (U.S)
- Olympus Corporation · Japan
- Johnson & Johnson Services, Inc. (U.S.)
- Cardinal Health. (U.S.)
Frequently asked questions
The Middle East Medical Devices market size was valued at $6 billion in 2024.
Cite this report
Meticulous Research. (2024). Middle East Medical Devices Market - Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MR-1418). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/middle-east-medical-devices-market-6101